Clobetasol Propionate

   
Google
 
Web NewDrugInformation.com

Clobetasol Propionate


Drug - Clobetasol Propionate
The trade name of the product as shown on the labeling.

Dosage - SOLUTION; TOPICAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Clobetasol Propionate
Multiple ingredients are in alphabetical order.

Strength - 0.05%
The potency of the active ingredient(s), Clobetasol Propionate. May repeat for multiple part products.

Applicant - TARO
The firm name holding legal responsibility for Clobetasol Propionate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 075224
The FDA assigned number to Clobetasol Propionate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Clobetasol Propionate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AT
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Nov 16, 1998
The date Clobetasol Propionate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Clobetasol Propionate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Clobetasol Propionate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Taro Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Clobetasol Propionate.

Clobetasol Propionate